Diabetes drugs could help combat lung cancer
The study involved an assessment of the medical records of 157 patients who had survived lung cancer and who also had diabetes. People who had taken either a metformin drug or a TZD were significantly less likely to have advanced lung cancer that had spread.
Peter Mazzone, from the Cleveland Clinic in Ohio, who led the study, said "Our study, as well as other research, suggests an association between metformin and/or TZD use and the risk of developing lung cancer."
He added "However, unique to this study, we have been able to report less advanced cancer in those who do develop cancer, a decreased frequency of squamous cell and small cell carcinomas, and improved survival, when controlled for stage, in people taking metformin and/or TZDs."
The researchers hope that it may be possible in the future to give metformin to smokers with lung cancer as a preventative measure. Although there is growing evidence of drugs having a beneficial effect on the treatment of lung cancer, more work will need to be done before this is possible.
Also related to this storyDiabetes Chat
Diabetes Book Reviews
Healthcare Professionals and Diabetes
Diabetes Guides for Diabetics in India
Blood Glucose Meter Giveaway
Diabetes and Pensions
The Diet Plate Clinically Proven to Control Diabetes
Diabetes and Alcohol
New diabetes drugs being developed
Heart risk not alleviated by diabetes drugs
Med diet could delay diabetes drugs
Study confirms how diabetes drugs can increase heart risk
Salt influence on diabetes drugs
Making Third world diabetes drugs cheaper
Diabetes drugs under review
Suspect held over deadly diabetes drugs